Preconference Skills Course
Abstract: In the context of the growing opioid epidemic, increasing numbers of patients with opioid use disorder (OUD) are being hospitalized, notably overdoses and infectious complications. As such, inpatient medical hospitalizations are now seen as critical opportunities to identify and manage OUDs, especially the initiation of medication treatment such as buprenorphine or methadone. However, pharmacotherapies for OUD continue to be under-utilized despite the robust evidence base. Consultation-liaison (CL) psychiatrists are therefore in an important position to guide medical colleagues on the use of these effective pharmacotherapies as well as assisting in the management of OUD-related issues that arise during a hospitalization. In addition to buprenorphine, this course will provide an overview of all medication options for the treatment of OUD, including methadone and long-acting naltrexone. An entire hour will be devoted solely to case discussions, with participants split into small groups to allow for interactive discussion with the faculty.
The Drug Abuse Treatment Act of 2000 mandates that only those practitioners who complete an approved course may prescribe buprenorphine. While CL psychiatrists in the hospital may not routinely write buprenorphine prescriptions, this course will provide an overview of OUD management in the hospital. For those participants who treat OUD patients, such as the CL psychiatrists working in a collaborative care setting, completion of this course will not only qualify the CL psychiatrist to apply for the DEA waiver necessary to prescribe buprenorphine, but also provide additional knowledge and skills to treat special populations such as pregnant OUD patients and those with co-morbid acute and chronic pain.
This 4-hour pre-conference waiver course is part of the mandated 8-hour course that is approved by the American Academy of Addicion Psychiatry, but will include content that is specifically geared towards CL psychiatrists. All attendees will be eligible to apply for a DEA waiver by completing an additional 4-hours of online training, which can be completed following the ACLP meeting without any additional cost.